Fibroblast Growth Factor 19 Improves LPS-Induced Lipid Disorder and Organ Injury by Regulating Metabolomic Characteristics in Mice

Sepsis is extremely heterogeneous pathology characterized by complex metabolic changes. Fibroblast growth factor 19 (FGF19) is a well-known intestine-derived inhibitor of bile acid biosynthesis. However, it is largely unknown about the roles of FGF19 in improving sepsis-associated metabolic disorder...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tiantian, Tang, Xiaomeng, Cui, Yun, Xiong, Xi, Xu, Yaya, Hu, Shaohua, Feng, Shuyun, Shao, Lujing, Ren, Yuqian, Miao, Huijie, Zhang, Hong, Zhu, Xiaodong, Zhang, Yucai, Wang, Chunxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279090/
https://www.ncbi.nlm.nih.gov/pubmed/35847588
http://dx.doi.org/10.1155/2022/9673512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279090/
https://www.ncbi.nlm.nih.gov/pubmed/35847588
http://dx.doi.org/10.1155/2022/9673512

Ejemplares similares